{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:15:56Z","timestamp":1794118556360,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ejso.2016.03.023","type":"journal-article","created":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T06:46:57Z","timestamp":1460443617000},"page":"956-964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Management of the axilla after neoadjuvant chemotherapy for clinically node positive breast cancer: A nationwide survey study in The Netherlands"],"prefix":"10.1016","volume":"42","author":[{"given":"G.","family":"Vugts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.G.","family":"Maaskant-Braat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.K.","family":"de Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.","family":"Voogd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.A.P.","family":"Nieuwenhuijzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2016.03.023_bib1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/bjs.5207","article-title":"A\u00a0risk index for early node-negative breast cancer","volume":"93","author":"Boyages","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2016.03.023_bib2","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1016\/j.ejca.2006.06.028","article-title":"Generalisability of survival estimates for patients with breast cancer \u2013 a comparison across two population-based series","volume":"42","author":"Lundin","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2016.03.023_bib3","first-page":"557","article-title":"A\u00a0clinical and histological study of certain adenocarcinomata of the breast: and a brief consideration of the supraclavicular operation and of the results of operations for cancer of the breast from 1889 to 1898 at the Johns Hopkins Hospital","volume":"28","author":"Halsted","year":"1898","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2016.03.023_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/ca.20812","article-title":"Historical review of breast lymphatic studies","volume":"22","author":"Suami","year":"2009","journal-title":"Clin Anat"},{"key":"10.1016\/j.ejso.2016.03.023_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","article-title":"Lymphatic mapping and sentinel lymphadenectomy for breast cancer","volume":"220","author":"Giuliano","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2016.03.023_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/cncr.21568","article-title":"Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis","volume":"106","author":"Kim","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2016.03.023_bib7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial","volume":"252","author":"Giuliano","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2016.03.023_bib8","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2016.03.023_bib9","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1200\/JCO.1998.16.8.2672","article-title":"Effect of preoperative chemotherapy on the outcome of women with operable breast cancer","volume":"16","author":"Fisher","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2016.03.023_bib10","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1245\/s10434-011-2108-2","article-title":"Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer","volume":"19","author":"Kaufmann","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2016.03.023_bib11","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1200\/JCO.2001.19.22.4224","article-title":"Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902","volume":"19","author":"van der Hage","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2016.03.023_bib12","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1245\/s10434-012-2484-2","article-title":"The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer","volume":"19","author":"Alvarado","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2016.03.023_bib13","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1245\/s10434-013-2902-0","article-title":"Early assessment of axillary response with (1)(8)F-FDG PET\/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla","volume":"20","author":"Koolen","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2016.03.023_bib14","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1200\/JCO.20.5.1304","article-title":"Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes","volume":"20","author":"Rouzier","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2016.03.023_bib15","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.ejca.2009.04.029","article-title":"Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer","volume":"45","author":"Straver","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2016.03.023_bib16","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cncr.25152","article-title":"Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer","volume":"116","author":"Dominici","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2016.03.023_bib17","doi-asserted-by":"crossref","first-page":"9304","DOI":"10.1200\/JCO.2005.02.5023","article-title":"Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy","volume":"23","author":"Hennessy","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2016.03.023_bib18","series-title":"Richtlijn behandeling van het mammacarcinoom","author":"NABON","year":"2012"},{"key":"10.1016\/j.ejso.2016.03.023_bib19","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1245\/s10434-013-3118-z","article-title":"Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer","volume":"20","author":"Hieken","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2016.03.023_bib20","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ejso.2016.03.023_bib21","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2016.03.023_bib22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2016.03.023_bib23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ejso.2007.04.007","article-title":"The feasibility of sentinel node biopsy in the previously treated breast","volume":"34","author":"Koizumi","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2016.03.023_bib24","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1245\/s10434-014-3775-6","article-title":"Implementation of the american college of surgeons oncology group z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy?","volume":"21","author":"Mittendorf","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2016.03.023_bib25","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/annonc\/mdp322","article-title":"Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009","volume":"20","author":"Goldhirsch","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2016.03.023_bib26","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/annonc\/mdl398","article-title":"First\u2013select the target: better choice of adjuvant treatments for breast cancer patients","volume":"17","author":"Goldhirsch","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2016.03.023_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01840834","article-title":"The Nottingham prognostic index in primary breast cancer","volume":"22","author":"Galea","year":"1992","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejso.2016.03.023_bib28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jnci\/dji021","article-title":"Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis","volume":"97","author":"Mauri","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2016.03.023_bib29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00259-013-2515-7","article-title":"Sequential (18)F-FDG PET\/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapy","volume":"41","author":"Koolen","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejso.2016.03.023_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/RLI.0b013e318277f056","article-title":"Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study","volume":"48","author":"Schipper","year":"2013","journal-title":"Invest Radiol"},{"key":"10.1016\/j.ejso.2016.03.023_bib31","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/bjs.9955","article-title":"Two decades of axillary management in breast cancer","volume":"102","author":"Beek","year":"2015","journal-title":"Br J Surg"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798316300373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798316300373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T17:26:15Z","timestamp":1655486775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798316300373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0748798316300373"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2016.03.023","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of the axilla after neoadjuvant chemotherapy for clinically node positive breast cancer: A nationwide survey study in The Netherlands","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2016.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}